We could not find any results for:
Make sure your spelling is correct or try broadening your search.
EDISON EQUITY RESEARCH: SYMBIO PHARMACEUTICALS - WITH EXPERIENCE COMES CONFIDENCEThree steps forward, one step back. With the December filing of three supplemental NDAs for Treakisym, SymBio is...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
26 | 0 | 0 | 1.21 | 1.21 | 1.21 | 0 | 0 | DR |
52 | -0.39 | -24.375 | 1.6 | 1.6 | 1.21 | 265 | 1.39396226 | DR |
156 | -5.77 | -82.664756447 | 6.98 | 6.98 | 1.21 | 232 | 2.94288852 | DR |
260 | -1.24 | -50.612244898 | 2.45 | 6.98 | 1.21 | 180 | 2.94288852 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions